Novo Nordisk

A Weight-Loss Shot for Alcohol Addiction? What New Data Reveals

A Weight-Loss Shot for Alcohol Addiction? What New Data Reveals

BY Outlook Business Desk

Inside the Scramble for India’s Post-Patent Semaglutide Market

One Goal, 50 Brands: Inside the Scramble for India’s Post-Patent Semaglutide Market

BY Shashank Bhatt

Novo Nordisk

Novo Nordisk Cuts Ozempic, Wegovy Prices by Up to 48% Amid Generic Pressure

BY Outlook Business Desk

Nova Nordisks

Indian Pharma Lines Up for Ozempic-Like Weight-Loss Drugs

BY Outlook Business Desk

Sun Pharma Gets DCGI Nod For Generic Weight-Loss Drug Amid Patent Fight With Novo Nordisk

Sun Pharma Gets DCGI Nod For Generic Weight-Loss Drug

BY Outlook Business Desk

Danish Novo Holdings Acquires 49% Stake in Pune’s Surya Hospitals

Novo Holdings Acquires 49% Stake in Surya Hospitals

BY Outlook Business Desk

Shutterstock

Natco Challenges Novo Nordisk’s Semaglutide Patent

BY Outlook Business Desk

Advertisement

Novo Nordisk

Novo Nordisk Rolls Out Ozempic in India

BY Outlook Business Desk

Dr Reddys

Delhi HC Allows Dr Reddy’s to Export Weight-Loss Drug

BY Outlook Business Desk